RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET

7.1 GLOBAL RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA RADIOISOTOPES IN NUCLEAR MEDICINE (RI) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 Agfa-Gevaert Group

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Braco

16.3 Cardiarc

16.4 Cardinal Health

16.5 CMR Naviscan (Gamma Medica Inc)

16.6 Curium

16.7 Digirad

16.8 GE Healthcare

16.9 Nordion (Canada)

16.10 NTP Radioisotopes SOC

16.11 Positron

16.12 Segami

16.13 Siemens Healthcare

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER